Cleared Traditional

K221031 - Arthrex DualCompression Hindfoot Fusion Nail Implant System (FDA 510(k) Clearance)

Dec 2022
Decision
257d
Days
Class 2
Risk

K221031 is an FDA 510(k) clearance for the Arthrex DualCompression Hindfoot Fusion Nail Implant System. This device is classified as a Rod, Fixation, Intramedullary And Accessories (Class II - Special Controls, product code HSB).

Submitted by Arthrex, Inc. (Naples, US). The FDA issued a Cleared decision on December 20, 2022, 257 days after receiving the submission on April 7, 2022.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3020.

Submission Details

510(k) Number K221031 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 07, 2022
Decision Date December 20, 2022
Days to Decision 257 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code HSB — Rod, Fixation, Intramedullary And Accessories
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3020

Similar Devices — HSB Rod, Fixation, Intramedullary And Accessories

All 33
Arthrex Humeral Nails
K252016 · Arthrex, Inc. · Mar 2026
Affixus Retrograde Femoral Nailing System
K253566 · Zimmer, Inc. · Mar 2026
Arthrex FibuLock Nail System
K252196 · Arthrex, Inc. · Mar 2026
Phantom® Hindfoot TTC/TC Nail System
K253591 · Paragon 28, Inc. · Mar 2026
T2 Alpha Femur Retrograde Nailing System
K253640 · Stryker GmbH · Feb 2026
ARIX Femur Nail System
K252826 · Jeil Medical Corporation · Dec 2025